Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Collado

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
International Journal of STD & AIDS|September 7, 2022
Weight changes after first-line antiretroviral initiation in a cohort of HIV-positive patients in Southern Spain (CAPOTA study)Cristina Gómez-Ayerbe, Rosario Palacios, Marisa Mayorga, et al.
The Journal of Infection|May 18, 2019
Higher relapse rate among HIV/HCV-coinfected patients receiving sofosbuvir/ledipasvir for 8 vs 12 weeksAnaïs Corma-Gómez, Juan Macías, Dolores Merino Muñoz, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 2, 2020
Progression to hepatitis C virus micro-elimination in people living with HIV in SpainAntonio Rivero-Juarez, Francisco Tellez, Maria Isabel Mayorga, et al.
The Journal of Infection|June 14, 2022
High efficacy of glecaprevir/pibrentasvir for HCV-infected individuals with active drug useAlejandro Gonzalez-Serna, Juan Macias, Anaïs Corma-Gomez, et al.
Plos One|February 6, 2016
Liver Toxicity of Current Antiretroviral Regimens in HIV-Infected Patients with Chronic Viral Hepatitis in a Real-Life Setting: The HEPAVIR SEG-HEP CohortKarin Neukam, José A Mira, Antonio Collado, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 3, 2007
Long term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in non-resectable locally advanced (stage IV-B) squamous cell head and neck carcinoma and peripheral blood stem cell support (PBSCS) with febrile neutropeniaFernando Rivera, María E Vega-Villegas, Marta F López-Brea, et al.
The Journal of Antimicrobial Chemotherapy|September 10, 2011
Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patientsKarin Neukam, José A Mira, Josefa Ruiz-Morales, et al.
The Journal of Antimicrobial Chemotherapy|June 24, 2008
Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimenManuel Crespo, José A Mira, Juan A Pineda, et al.
AIDS (London, England)|May 6, 2008
Baseline serum low-density lipoprotein cholesterol levels predict response to hepatitis C virus therapy in HIV/hepatitis C virus coinfected patientsJosé del Valle, José A Mira, Ignacio de los Santos, et al.
HIV Clinical Trials|February 16, 2018
Paritaprevir/ritonavir/ombitasvir plus dasabuvir in HIV/HCV-coinfected patients with genotype 1 in real-life practiceJuan A Pineda, Antonio Rivero-Juárez, Ignacio de Los Santos, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
International Journal of STD & AIDS|September 7, 2022
Weight changes after first-line antiretroviral initiation in a cohort of HIV-positive patients in Southern Spain (CAPOTA study)Cristina Gómez-Ayerbe, Rosario Palacios, Marisa Mayorga, et al.
The Journal of Infection|May 18, 2019
Higher relapse rate among HIV/HCV-coinfected patients receiving sofosbuvir/ledipasvir for 8 vs 12 weeksAnaïs Corma-Gómez, Juan Macías, Dolores Merino Muñoz, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 2, 2020
Progression to hepatitis C virus micro-elimination in people living with HIV in SpainAntonio Rivero-Juarez, Francisco Tellez, Maria Isabel Mayorga, et al.
The Journal of Infection|June 14, 2022
High efficacy of glecaprevir/pibrentasvir for HCV-infected individuals with active drug useAlejandro Gonzalez-Serna, Juan Macias, Anaïs Corma-Gomez, et al.
Plos One|February 6, 2016
Liver Toxicity of Current Antiretroviral Regimens in HIV-Infected Patients with Chronic Viral Hepatitis in a Real-Life Setting: The HEPAVIR SEG-HEP CohortKarin Neukam, José A Mira, Antonio Collado, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 3, 2007
Long term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in non-resectable locally advanced (stage IV-B) squamous cell head and neck carcinoma and peripheral blood stem cell support (PBSCS) with febrile neutropeniaFernando Rivera, María E Vega-Villegas, Marta F López-Brea, et al.
The Journal of Antimicrobial Chemotherapy|September 10, 2011
Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patientsKarin Neukam, José A Mira, Josefa Ruiz-Morales, et al.
The Journal of Antimicrobial Chemotherapy|June 24, 2008
Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimenManuel Crespo, José A Mira, Juan A Pineda, et al.
AIDS (London, England)|May 6, 2008
Baseline serum low-density lipoprotein cholesterol levels predict response to hepatitis C virus therapy in HIV/hepatitis C virus coinfected patientsJosé del Valle, José A Mira, Ignacio de los Santos, et al.
HIV Clinical Trials|February 16, 2018
Paritaprevir/ritonavir/ombitasvir plus dasabuvir in HIV/HCV-coinfected patients with genotype 1 in real-life practiceJuan A Pineda, Antonio Rivero-Juárez, Ignacio de Los Santos, et al.
Pageof 8